Dietary antioxidants and long-term risk of dementia
- PMID: 20625087
- PMCID: PMC2923546
- DOI: 10.1001/archneurol.2010.144
Dietary antioxidants and long-term risk of dementia
Abstract
Background: The Rotterdam Study previously found that higher dietary intakes of vitamins E and C related to lower risk of dementia and Alzheimer disease (AD) over 6 years of follow-up.
Objective: To study consumption of major dietary antioxidants relative to long-term risk of dementia.
Design: Population-based prospective cohort study.
Setting: The Rotterdam Study in the Netherlands.
Participants: A total of 5395 participants, 55 years and older, who were free of dementia and provided dietary information at study baseline.
Main outcome measures: Incidence of dementia and AD, based on internationally accepted criteria, relative to dietary intake of vitamin E, vitamin C, beta carotene, and flavonoids.
Results: During a mean follow-up period of 9.6 years, dementia developed in 465 participants, of whom 365 were diagnosed as having AD. In multivariate models adjusted for age, education, apolipoprotein E epsilon4 genotype, total energy intake, alcohol intake, smoking habits, body mass index, and supplement use, higher intake of vitamin E at study baseline was associated with lower long-term risk of dementia (P = .02 for trend). Compared with participants in the lowest tertile of vitamin E intake, those in the highest tertile were 25% less likely to develop dementia (hazard ratio, 0.75; 95% confidence interval, 0.59-0.95 with adjustment for potential confounders). Dietary intake levels of vitamin C, beta carotene, and flavonoids were not associated with dementia risk after multivariate adjustment (P > .99 for trend for vitamin C and beta carotene and P = .60 for trend for flavonoids). Results were similar when risk for AD was specifically assessed.
Conclusion: Higher intake of foods rich in vitamin E may modestly reduce long-term risk of dementia and AD.
Conflict of interest statement
Similar articles
-
Dietary intake of antioxidants and risk of Alzheimer disease.JAMA. 2002 Jun 26;287(24):3223-9. doi: 10.1001/jama.287.24.3223. JAMA. 2002. PMID: 12076218
-
Dietary antioxidants and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study.Ophthalmology. 2008 Feb;115(2):334-41. doi: 10.1016/j.ophtha.2007.03.083. Epub 2007 Jul 30. Ophthalmology. 2008. PMID: 17664009
-
Dietary antioxidants and risk of myocardial infarction in the elderly: the Rotterdam Study.Am J Clin Nutr. 1999 Feb;69(2):261-6. doi: 10.1093/ajcn/69.2.261. Am J Clin Nutr. 1999. PMID: 9989690
-
Dietary antioxidants, cognitive function and dementia--a systematic review.Plant Foods Hum Nutr. 2013 Sep;68(3):279-92. doi: 10.1007/s11130-013-0370-0. Plant Foods Hum Nutr. 2013. PMID: 23881465 Review.
-
Effect of antioxidant intake patterns on risks of dementia and cognitive decline.Eur Geriatr Med. 2023 Feb;14(1):9-17. doi: 10.1007/s41999-022-00720-7. Epub 2022 Nov 29. Eur Geriatr Med. 2023. PMID: 36445640 Review.
Cited by
-
The relationship between micronutrients and cognitive ability in an elderly population with mild cognitive impairment and Alzheimer's disease: a cross-sectional study.BMC Neurol. 2024 Oct 25;24(1):416. doi: 10.1186/s12883-024-03800-2. BMC Neurol. 2024. PMID: 39455919 Free PMC article.
-
Mediating effects of physical activities and cognitive function on the relationship between dietary diversity and all-cause mortality in community-dwelling older adults.J Glob Health. 2024 Oct 25;14:04169. doi: 10.7189/jogh.14.04169. J Glob Health. 2024. PMID: 39451052 Free PMC article.
-
Flavonoid-Rich Fruit Intake in Midlife and Late-Life and Associations with Risk of Dementia: The Framingham Heart Study.J Prev Alzheimers Dis. 2024;11(5):1270-1279. doi: 10.14283/jpad.2024.116. J Prev Alzheimers Dis. 2024. PMID: 39350372 Free PMC article.
-
Midlife Residential Greenness and Late-Life Cognitive Decline among Nurses' Health Study Participants.Environ Health Perspect. 2024 Jul;132(7):77003. doi: 10.1289/EHP13588. Epub 2024 Jul 17. Environ Health Perspect. 2024. PMID: 39016600 Free PMC article.
-
Review on anti-alzheimer drug development: approaches, challenges and perspectives.RSC Adv. 2024 Apr 5;14(16):11057-11088. doi: 10.1039/d3ra08333k. eCollection 2024 Apr 3. RSC Adv. 2024. PMID: 38586442 Free PMC article. Review.
References
-
- Behl C. Amyloid beta-protein toxicity and oxidative stress in Alzheimer’s disease. Cell Tissue Res. 1997 Dec;290(3):471–480. - PubMed
-
- Christen Y. Oxidative stress and Alzheimer disease. Am J Clin Nutr. 2000 Feb;71(2):621S–629S. - PubMed
-
- Montiel T, Quiroz-Baez R, Massieu L, Arias C. Role of oxidative stress on beta-amyloid neurotoxicity elicited during impairment of energy metabolism in the hippocampus: protection by antioxidants. Exp Neurol. 2006 Aug;200(2):496–508. - PubMed
-
- Rota C, Rimbach G, Minihane AM, Stoecklin E, Barella L. Dietary vitamin E modulates differential gene expression in the rat hippocampus: potential implications for its neuroprotective properties. Nutr Neurosci. 2005 Feb;8(1):21–29. - PubMed
-
- Yamada K, Tanaka T, Han D, Senzaki K, Kameyama T, Nabeshima T. Protective effects of idebenone and alpha-tocopherol on beta-amyloid-(1-42)-induced learning and memory deficits in rats: implication of oxidative stress in beta-amyloid-induced neurotoxicity in vivo. Eur J Neurosci. 1999 Jan;11(1):83–90. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
